Literature DB >> 22008697

Pulsatile venous waveform quality affects the conduit performance in functional and "failing" Fontan circulations.

Onur Dur1, Ergin Kocyildirim, Ozlem Soran, Peter D Wearden, Victor O Morell, Curt G DeGroff, Kerem Pekkan.   

Abstract

OBJECTIVE: To investigate the effect of pulsatility of venous flow waveform in the inferior and superior caval vessels on the performance of functional and "failing" Fontan patients based on two primary performance measures - the conduit power loss and the distribution of inferior caval flow (hepatic factors) to the lungs.
METHODS: Doppler angiography flows were acquired from two typical extra-cardiac conduit "failing" Fontan patients, aged 13 and 25 years, with ventricle dysfunction. Using computational fluid dynamics, haemodynamic efficiencies of "failing", functional, and in vitro-generated mechanically assisted venous flow waveforms were evaluated inside an idealised total cavopulmonary connection with a caval offset. To investigate the effect of venous pulsatility alone, cardiac output was normalised to 3 litres per minute in all cases. To quantify the pulsatile behaviour of venous flows, two new performance indices were suggested.
RESULTS: Variations in the pulsatile content of venous waveforms altered the conduit efficiency notably. High-frequency and low-amplitude oscillations lowered the pulsatile component of the power losses in "failing" Fontan flow waveforms. Owing to the offset geometry, hepatic flow distribution depended strongly on the ratio of time-dependent caval flows and the pulsatility content rather than mixing at the junction. "Failing" Fontan flow waveforms exhibited less balanced hepatic flow distribution to lungs.
CONCLUSIONS: The haemodynamic efficiency of single-ventricle circulation depends strongly on the pulsatility of venous flow waveforms. The proposed performance indices can be calculated easily in the clinical setting in efforts to better quantify the energy efficiency of Fontan venous waveforms in pulsatile settings.

Entities:  

Mesh:

Year:  2011        PMID: 22008697     DOI: 10.1017/S1047951111001491

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  6 in total

1.  Can time-averaged flow boundary conditions be used to meet the clinical timeline for Fontan surgical planning?

Authors:  Zhenglun Alan Wei; Phillip M Trusty; Mike Tree; Christopher M Haggerty; Elaine Tang; Mark Fogel; Ajit P Yoganathan
Journal:  J Biomech       Date:  2016-11-10       Impact factor: 2.712

2.  The effect of respiration-driven flow waveforms on hemodynamic metrics used in Fontan surgical planning.

Authors:  Elaine Tang; Zhenglun Alan Wei; Phillip M Trusty; Kevin K Whitehead; Lucia Mirabella; Alessandro Veneziani; Mark A Fogel; Ajit P Yoganathan
Journal:  J Biomech       Date:  2018-10-25       Impact factor: 2.712

3.  Effect of flow pulsatility on modeling the hemodynamics in the total cavopulmonary connection.

Authors:  Reza H Khiabani; Maria Restrepo; Elaine Tang; Diane De Zélicourt; Fotis Sotiropoulos; Mark Fogel; Ajit P Yoganathan
Journal:  J Biomech       Date:  2012-07-28       Impact factor: 2.712

4.  Fontan conversion templates: patient-specific hemodynamic performance of the lateral tunnel versus the intraatrial conduit with fenestration.

Authors:  Haifa Hong; Onur Dur; Haibo Zhang; Zhongqun Zhu; Kerem Pekkan; Jinfen Liu
Journal:  Pediatr Cardiol       Date:  2013-03-09       Impact factor: 1.655

5.  Mock circulatory system of the Fontan circulation to study respiration effects on venous flow behavior.

Authors:  Marija Vukicevic; John A Chiulli; Timothy Conover; Giancarlo Pennati; Tain Yen Hsia; Richard S Figliola
Journal:  ASAIO J       Date:  2013 May-Jun       Impact factor: 2.872

6.  Heart beat but not respiration is the main driving force of the systemic venous return in the Fontan circulation.

Authors:  Dominik Daniel Gabbert; Christopher Hart; Michael Jerosch-Herold; Philip Wegner; Mona Salehi Ravesh; Inga Voges; Ines Kristo; Abdullah A L Bulushi; Jens Scheewe; Arash Kheradvar; Hans-Heiner Kramer; Carsten Rickers
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.